To study the drug useful in increasing the efficacy of spinal anesthesia
Phase 3
- Conditions
- Health Condition 1: null- Posted for elective surgeries
- Registration Number
- CTRI/2017/08/009281
- Lead Sponsor
- Father Muller hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Patients between age 15-65yrs undergoing elective surgery .
2 ASA class I and 2.
Exclusion Criteria
1 Patients with cardiac disease, heart block, dysarrythmia, beta blockers and alpha antagonist 2 ASA class 3 and 4.
3 Patients not wiling for spinal anaesthesia.
4 Allergy to drugs.
5 History of drug abuse, space occupying lesion, bleeding disorders.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To check which drug has better outcome as adjuvants to intrathecal BupivacaineTimepoint: FOR A PERIOD OF 2 YEARS <br/ ><br>June 2018 <br/ ><br>
- Secondary Outcome Measures
Name Time Method To monitor its effect on post operative pain reliefTimepoint: For a period of 2 years <br/ ><br>june 2018